Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-27T02:37:52.873Z Has data issue: false hasContentIssue false

Quantification and Identification of Visible and Subvisible Particulates from Elastomeric Components Contributing to the Total Particle Count of Pharmaceutical Products

Published online by Cambridge University Press:  04 August 2017

Evita McPherson
Affiliation:
Luitpold Pharmaceuticals, QC Particulate Laboratory, Shirley NY, United States.
Christopher Bingham
Affiliation:
Luitpold Pharmaceuticals, QC Particulate Laboratory, Shirley NY, United States.
Danequa Carter
Affiliation:
Luitpold Pharmaceuticals, QC Particulate Laboratory, Shirley NY, United States.
William Toomey
Affiliation:
Luitpold Pharmaceuticals, QC Particulate Laboratory, Shirley NY, United States.
Megan Scofield
Affiliation:
Luitpold Pharmaceuticals, QC Particulate Laboratory, Shirley NY, United States.
Rebecca Pulvirenti
Affiliation:
Luitpold Pharmaceuticals, QC Particulate Laboratory, Shirley NY, United States.

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Abstract
Copyright
© Microscopy Society of America 2017 

References

[1] <788> Particulate Matter in Injections. In: The United States Pharmacopeia, 35th revision. Rockville, MD: The United States Pharmacopeial Convention, (2012).+Particulate+Matter+in+Injections.+In:+The+United+States+Pharmacopeia,+35th+revision.+Rockville,+MD:+The+United+States+Pharmacopeial+Convention,+(2012).>Google Scholar
[2] Internal Standard ISO 8871-3: Elastomeric Parts for Parenterals and for Devices for Pharmaceutical Use — Part 3: Determination of Released-Particle Count, First Edition, 2003.Google Scholar
[3] Scott Aldrich is thanked for his many useful discussions and contributions to this work.Google Scholar